The European Association of Hospital Pharmacists
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 16 Jul 2025 | Sandra Gallina Director-General | Exchange of views on the state of play and next steps for the medical devices sector. | — |
| 16 Jul 2025 | Flora Giorgio Head of Unit | Exchange of views on the state of play and next steps for the medical devices sector. | — |
| 16 Jul 2025 | Flora Giorgio Head of Unit | Exchange of views on the state of play and next steps for the medical devices sector. | SRC |
| 16 Jul 2025 | Sandra Gallina Director-General | Exchange of views on the state of play and next steps for the medical devices sector. | SRC |
| 14 Jan 2025 | Ariane Vander Stappen Head of Unit | Discussion on Antimicrobial Resistance | SRC |
| 14 Jan 2025 | Ariane Vander Stappen Head of Unit | Discussion on Antimicrobial Resistance | — |
| 16 Jun 2021 | Margaritis Schinas Vice-President | Supply chains for medicines | — |
| 16 Jun 2021 | Maria Luisa Llano Cardenal Cabinet member | Supply chains for medicines | SRC |
| 16 Jun 2021 | Margaritis Schinas Vice-President | Supply chains for medicines | SRC |
| 30 Sept 2020 | Karolina Herbout-Borczak Cabinet member | Call with pharmaceutical and medical device supply Chain on COVID-19 | — |
| 30 Sept 2020 | Karolina Herbout-Borczak Cabinet member | Call with pharmaceutical and medical device supply Chain on COVID-19 | SRC |
| 22 Sept 2020 | Stella Kyriakides Commissioner | Exchange of views on the upcoming Pharmaceutical Strategy, shortages of medicines and the role of health workforce in the health systems | — |
| 22 Sept 2020 | Stella Kyriakides Commissioner | Exchange of views on the upcoming Pharmaceutical Strategy, shortages of medicines and the role of health workforce in the health systems | SRC |
| 22 Jul 2019 | Vytenis Andriukaitis Commissioner | Access to medicines | SRC |
| 22 Jul 2019 | Vytenis Andriukaitis Commissioner | Access to medicines | — |
| 01 Jul 2019 | Anne Bucher Director-General | • The current medicines shortages situation in Europe; • Our request for an investigation into the causes of shortages; and, • The general need for better information sharing about shortages. | — |
| 01 Jul 2019 | Anne Bucher Director-General | • The current medicines shortages situation in Europe; • Our request for an investigation into the causes of shortages; and, • The general need for better information sharing about shortages. | SRC |
| 03 May 2018 | Vytenis Andriukaitis Commissioner | HTA | — |
| 03 May 2018 | Vytenis Andriukaitis Commissioner | HTA | SRC |
Mission & Goals
EAHP is an association of 37 national hospital pharmacy associations. Its mission is to represent and develop the hospital pharmacy profession within Europe to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals In the interest of patients and public health, EAHP seeks to - to promote and further develop hospital pharmacy and to obtain and maintain general joint pharmaceutical principles and a joint pharmaceutical policy; - to foster research and education activities; - to promote co-operation with other organisations in the domain of public health; - to promote the position and function of hospital pharmacists; - to support and uphold the interests of hospital pharmacists Detailed information on the goals of EAHP can be found under
EU Legislative Interests
The main EU initiatives, policies and legislative files currently followed by EAHP include developments in: - Shortages (including Critical Medicines Alliance, Union list of critical Medicines, MSSG, etc.) -Procurement of Medicines and Medical Devices -Revision of the pharmaceutical legislation -Healthcare Workforce shortage and creation of a talent pool -Recognition of professional qualification and specialisations - Access to medicines -Health Technology Assessment -ATMPs -Orphan Medicinal Products -Europe's beating cancer plan - Clinical trial regulation - Medical devices regulation - EU initiatives in the area of health systems - tackling antimicrobial resistance, including the better use of antibiotics and an improved research environment for new antibiotics and promotion of a One health Approach - Digital health (including ePI, EDHS and AI Act) - Patient safety - The implementation of the Falsified Medicines Directive
Communication Activities
-Joint communication campaign with EMA on shortages -Communication campaign and exchanges with ECDC on AMR -Amendments on pending legislative files. -Position papers on key policy topics. -Joint statements and activities with other stakeholder organisations on topics of common interest. -EAHP international annual congress of EAHP -Academy Seminar Programme -Synergy Masterclass -Access to open learning courses -Scientific publications on the European Journal of Hospital Pharmacy (EJHP) -EU monitor (monthly newsletter) -Social Media Communication -Press releases -Participation in events of policy magazines (e.g. POLITICO) -Attendance of the meetings of the Interregional Group on Health and Wellbeing of the Committee of the Regions -Participation in events hosted by MEPs (e.g. on vaccination, shortages, rare diseases, etc.) -Collection of data through surveys and following analysis, draft and publication of the report and results (e.g. shortages, workforce, etc.) -Participation in policy events organised by other stakeholders organisations on topics of common interest. -Project aimed at creating a common training framework for the hospital pharmacy specialisation.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
EAHP is a member of the Federation of European & International Associations established in Belgium. www.faib.org EAHP is a member of the International Pharmaceutical Federation (FIP). www.fip.org EAHP is a member of the European Medicines Agency's Healthcare Professional's Working Party. http://www.ema.europa.eu/ EAHP is an affiliate stakeholder in the European Medicines Verification Organisation (EMVO) https://emvo-medicines.eu
Organisation Members
Information on the 37 national country members of EAHP is available on the EAHP website here: https://eahp.eu/about-us/members/
Connected Legislation
Coordinated action on antimicrobial resistance
Coordinated action on antimicrobial resistance
Taiwan's observer status at the World Health Assembly (2002)
Mental health
Resolution on Taiwan (56th World Health Assembly)
Prevention of injury and promotion of safety
Health data and indicators, to provide information back-up (cancer, AIDS, etc.)
Public exposure limits to electromagnetic fields (0Hz-300Hz)
Injury prevention (action in the field of public health)
Community health action programme (2007-2013)
Mental health for the European Union
Pandemic influenza preparedness and response planning
Mental health
Extension of EU public health action programmes
Mental Health
Antimicrobials reserved for human infections
Health concerns associated with electromagnetic fields
Summer-time arrangements
Mental Health
EU Health Emergency Preparedness and Response Authority
Public Health Community Action Programme (2001-2006)
Mental health
European Health Insurance Card